본문 바로가기
KERD
논문KCI 등재

挑仁이 일측 신절제와 streptozotocin으로 유발된 당뇨병성 신증 Rat에 미치는 영향

The Effects of Prunus on Diabetic Nephropathy Rats Induced by Unilateral Nephrectomy and Streptozotocin

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: Diabetic nephropathy is the most common cause of end stage renal disease. Transforming growth factor (TGF)-β1, type Ⅳ collagen, advanced glycation end-products (AGEs), and angiotensin II type 1 receptor (AT1) are the main factors of diabetic nephropathy. We investigated the effects of Prunus on renal function and histopathological changes of diabetic nephropathy rat model induced by unilateral nephrectomy and streptozotocin. Methods: Diabetes was induced in male Sprague-Dawley rats (290±10 g) by injecting streptozotocin (55 mg/kg) into the tail vein after unilateral nephrectomy. Rats were divided into 3 groups (n=6): normal, control, and Prunus. After 8 weeks of oral administration of Prunus extract on the Prunus group from 3 days after streptozotocin injection, we checked weight, 24 hrs urine, blood biochemistry and renal tissue to evaluate renal function and histopathological changes by examining parameters including albuminuria, BUN, creatinine, cholesterol, low density lipoprotein (LDL), triglyceride, TGF-β1, type Ⅳ collagen, AGEs, and AT1. We also measured mRNA expression of TGF-β1, type Ⅳ collagen, AGEs, and AT1 by Real Time polymerase chain reaction (RT-PCR). Results: Prunus decreased the amount of 24 hrs proteinuria, and inhibited histopathological changes of diabetic nephropathy including the expression and accumulation of TGF-β1, type Ⅳ collagen and AGEs which could promote development of diabetic nephropathy. Prunus also inhibited mRNA expression of TGF-β1, type Ⅳ collagen. Conclusions: These findings suggest that Prunus might protect the renal function and inhibit the development of renal injury by regulating factors including TGF-β1, type Ⅳ collagen, AGEs, except AT1, so Prunus can be used for diabetic patients to prevent the progression of diabetic nephropathy.

Abstract

Objectives: Diabetic nephropathy is the most common cause of end stage renal disease. Transforming growth factor (TGF)-β1, type Ⅳ collagen, advanced glycation end-products (AGEs), and angiotensin II type 1 receptor (AT1) are the main factors of diabetic nephropathy. We investigated the effects of Prunus on renal function and histopathological changes of diabetic nephropathy rat model induced by unilateral nephrectomy and streptozotocin. Methods: Diabetes was induced in male Sprague-Dawley rats (290±10 g) by injecting streptozotocin (55 mg/kg) into the tail vein after unilateral nephrectomy. Rats were divided into 3 groups (n=6): normal, control, and Prunus. After 8 weeks of oral administration of Prunus extract on the Prunus group from 3 days after streptozotocin injection, we checked weight, 24 hrs urine, blood biochemistry and renal tissue to evaluate renal function and histopathological changes by examining parameters including albuminuria, BUN, creatinine, cholesterol, low density lipoprotein (LDL), triglyceride, TGF-β1, type Ⅳ collagen, AGEs, and AT1. We also measured mRNA expression of TGF-β1, type Ⅳ collagen, AGEs, and AT1 by Real Time polymerase chain reaction (RT-PCR). Results: Prunus decreased the amount of 24 hrs proteinuria, and inhibited histopathological changes of diabetic nephropathy including the expression and accumulation of TGF-β1, type Ⅳ collagen and AGEs which could promote development of diabetic nephropathy. Prunus also inhibited mRNA expression of TGF-β1, type Ⅳ collagen. Conclusions: These findings suggest that Prunus might protect the renal function and inhibit the development of renal injury by regulating factors including TGF-β1, type Ⅳ collagen, AGEs, except AT1, so Prunus can be used for diabetic patients to prevent the progression of diabetic nephropathy.

참고문헌 (40)

  1. Futoshi Shintani, "Steps to Internal medicine", pp.49~52 (2005), 도서출판 정담
  2. 대한내과학회 해리슨내과학 편집위원회, "Harrion’s 내과학. Vol. 2", pp.2922~2957 (2013), MIP
  3. 서울대학교 의과대학 내과학교실, "최신지견 내과학(Ⅱ)", pp.1460~1472 (2003), 도서출판 고려의학
  4. 김성아, "당뇨병성 신증의 한의학적 접근및 치료에 대한 연구", 대한한의정보학회지, 11(2), pp.1~13 (2005)
  5. 두호경, "동의신계학", pp.1131~1141 (2003), 성보사
  6. 張天, "實用中醫腎病學", pp.712~718 (1992), 일중사
  7. 정형철, "Streptozotocin으로 유발된 흰쥐의 당뇨병성 신증에서 加味枸杞還童丸이 Oxidative Stress 및 Polyol Pathway에 미치는 영향", 동의생리병리학회지, 21(3), pp.671~678 (2007), 한의병리학회
  8. 신현권, "韓藥複合處方이 Streptozotocin으로 유발된 糖尿病 흰쥐의 血糖 및 糖尿病性 腎證 발현에 미치는 영향", 대한침구의학회지, 25(3), pp.110~120 (2008), 대한침구의학회
  9. 이연경, "加味五苓散이 Streptozotocin으로 유발된 흰쥐의 糖尿病性 腎症에 미치는 영향", 대한한방내과학회지, 33(4), pp.367~386 (2012), 대한한방내과학회
  10. 김영석, "단삼이 당뇨병성 신병증 Rat의 신기능 및 조직학적 변화에 미치는 영향", 대한한방내과학회지, 29(3), pp.787~799 (2008), 대한한방내과학회
  11. 서수환, "水蛭이 Streptozotocin으로 유발된 Rat의 糖尿病性 腎症에 미치는 影響", 대한한의학회지, 29(4), pp.133~145 (2008), 대한한의학회
  12. 김동훈, "三七根이 당뇨병성 신병증에 미치는 영향", 박사, 한의학과, pp.2013
  13. 김경국, "紅花가 일측 신절제와 streptozotocin으로 유발된 rat의 糖尿病性 腎症에 미치는 영향", 석사, 한의학과, pp.2013
  14. 김민석, "당뇨병성 신증 Rat에 牧丹皮가 미치는 영향", 박사, 한의학과, pp.2013
  15. 全國韓醫科大學 共同敎材編輯委員會, "本草學", pp.462~463 (2011), 永林社
  16. 이진태, "桃仁 껍질의 화장품약리활성 및 항염 효과", 대한본초학회지, 21(2), pp.87~93 (2006), 대한본초학회
  17. 윤왕수, "도인이 Triton WR-1339로 誘發된 흰쥐의 高旨血症에 미치는 影響", 대한예방한의학회지, 6(2), pp.128~136 (2002)
  18. 尹仁漢, "挑仁이 高Cholesterol 食餌에 의한 家兎의 粥狀動脈硬化에 미치는 影響", 박사, 한의학, pp.1996
  19. 이창근, "桃仁이 Endotoxin을 투여한 흰쥐의 혈액에 미치는 影響", Journal of Pharmacopuncture, 8(2), pp.59~65 (2005), 대한약침학회
  20. 金言國, "당뇨병성 혈관 장애에 대한 도인승기탕의개선 효과 연구", 박사, pp.2010
  21. Yokozawa T, "Animal model of diabetic nephropathy", Exp Toxic Pathol, 53, pp.359~363 (2001)
  22. Wei M, "The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes", Heart, Lung and Circulation, 12, pp.44~50 (2003)
  23. Brondum E, "Funtional abnormalities in isolated atteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models", Horm Metab Res, 37, pp.56~60 (2005)
  24. 범문에듀케이션 편집부, "병리학", pp.927~928 (2011), 범문에듀케이션
  25. 노정우, "임상신장학", pp.330~343 (2005), 대한신장학회
  26. 김용진, "당뇨병학", pp.585~603 (2011), 대한당뇨병학회
  27. 전국 한의과대학 신계내과학교실, "腎系內科學", pp.89~96 (2011), 군자출판사
  28. 양위, "681례의 만성신부전 환자에 대한 각 단계에서의 邪實兼證의 특점 분석", 동서의학, 27(1), pp.33~40 (2000)
  29. 陳以平, "腎病的辨證與辨病治療", pp.143~161 (2003), 人民衛生出版社
  30. 張介賓, "景岳全書", pp.2512~2513 (2006), 도서출판 한미의학
  31. 이태희, "당뇨병 유발 약물의 기전", 대한당뇨병학회지 당뇨병, 27(1), pp.1~15 (1993)
  32. Lopes GS, "Effect of unilateral nephrectomy on renal function of diabetic rats", Histol Histopathol, 19(4), pp.1085~1088 (2004)
  33. 서울대학교병원 신장내과, "임상 신장학 입문", pp.389~391 (2002), (주)신흥메드싸이언스
  34. 대한병리학회, , pp.770~777 (2011), 고문사(KMS)
  35. Sharma K, "The emerging role of transforming growth factor-β in kidney disease", Am J Physiol, 35(6), pp.829~842 (1994)
  36. 강영선, "당뇨병성 신증의 발병기전으로 족세포 (Podocyte)에서형질전환인자 (Transforming Growth Factor)β의 역할", Kidney Research and Clinical Practice, 22(6), pp.645~654 (2003), 대한신장학회
  37. 김용섭, "고농도 포도당에서 배양한 혈관사이질 세포에서 안지오텐신 Ⅱ와 안지오텐신 전환효소 억제제가 Procollagen α1(Ⅳ) mRNA 발현에 미치는 효과", 대한신장학회지, 19(1), pp.12~21 (2000)
  38. 대한내분비학회, "내분비대사학 (Textbook of Endocrinology and Metabolism) -2nd edition-", pp.713~720 (2011), 군자출판사
  39. 박정탁, "당뇨병성 신증의 병태생리", 대한내과학회지, 77(6), pp.670~677 (2009), 대한내과학회
  40. Atlas SA, "The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition", J Manag Care Pharm, 13, pp.9~20 (2007)

이 간행물의 다른 논문 (15건)